Asia BioPartnering Forum

As the largest Nordic event for digital health, health tech, person-centered care, Vitalis 2026 did indeed bring together the full life science and healthcare ecosystems.

On May 7, 21 exhibiting companies will take part in Umeå Lab Fair – the event was fully booked in just three hours.

The independent Data Monitoring Committee (DMC) of the Tumorad-01 study declared that a primary endpoint, identifying the maximum tolerated dose, has been met and recommends that an additional two patients are enrolled at the dose level of 15 MBq/kg to provide a basis for defining a recommended phase II dose and completion of the phase I part of the study.

When Encare was awarded the Swecare Export Award 2026, the company was highlighted as one of the Swedish healthtech companies that has succeeded in translating clinical research into concrete benefits in healthcare internationally.

The two companies have announced a global commercial launch resulting from their strategic collaboration.

As the largest Nordic event for digital health, health tech, person-centered care, Vitalis 2026 did indeed bring together the full life science and healthcare ecosystems.

The company has established manufacturing capacity in accordance with current quality requirements and regulatory guidelines, it states.